Peoples Financial Services Corp. Gilead Sciences, Inc. Transaction History

Peoples Financial Services Corp.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 14, 2021	SELL	$63.47 - $69.35 $81,114 - $88,629	-1,278 Closed	0 $0
Q1 2021 Apr 15, 2021	SELL	$60.0 - $68.46 $3,000 - $3,422	-50 Reduced 3.77%	1,278 $83,000
Q4 2020 Jan 12, 2021	SELL	$56.65 - $64.55 $7,081 - $8,068	-125 Reduced 8.6%	1,328 $77,000
Q2 2019 Jul 11, 2019	SELL	$61.87 - $69.38 $43,309 - $48,566	-700 Reduced 32.51%	1,453 $98,000
Q1 2019 Apr 18, 2019	BUY	$62.53 - $70.05 $43,771 - $49,035	700 Added 48.18%	2,153 $140,000
Q4 2018 Jan 14, 2019	BUY	$60.54 - $79.0 $36,324 - $47,400	600 Added 70.34%	1,453 $91,000
Q3 2018 Oct 12, 2018	SELL	$71.28 - $78.92 $14,256 - $15,784	-200 Reduced 18.99%	853 $66,000
Q1 2018 Apr 25, 2018	BUY	$72.84 - $88.8 $7,284 - $8,880	100 Added 10.49%	1,053 $80,000
Q3 2017 Oct 18, 2017	BUY	$72.11 - $85.47 $68,720 - $81,452	953	953 $77,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Peoples Financial Services Corp., based on Form 13F filings with the SEC.

Stay updated on Peoples Financial Services Corp. with notifications on news.